Dolby Laboratories, Inc. (DLB)
USD 77.17
(-1.66%)
USD 77.17
(-1.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 282.06 Million | 318.57 Million | 447.75 Million | 343.84 Million | 327.67 Million | 352.2 Million |
| Net Income | 191.73 Million | 183.89 Million | 317.82 Million | 231.61 Million | 255.5 Million | 122.8 Million |
| Depreciation & Amortization | 71.25 Million | 103.6 Million | 112.75 Million | 90.87 Million | 85.12 Million | 81.28 Million |
| Deferred income taxes | -21.65 Million | -29.46 Million | -37.04 Million | -5.27 Million | -40.19 Million | 89.93 Million |
| Stock-based compensation | 90.29 Million | 114.92 Million | 99.69 Million | 86.62 Million | 76.58 Million | 71.24 Million |
| Change in working capital | -42.61 Million | -56.25 Million | -24.63 Million | -81.05 Million | -94.42 Million | -25.61 Million |
| Other non-cash items | -6.94 Million | 1.86 Million | -20.83 Million | 21.04 Million | 45.08 Million | 12.55 Million |
| Investing Cash Flow | 73.91 Million | -295.93 Million | -44.9 Million | 134.37 Million | -56.22 Million | 78.25 Million |
| Investments in PPE | -22.15 Million | -59.45 Million | -54.45 Million | -68.98 Million | -113.53 Million | -85.35 Million |
| Acquisitions | 25.7 Million | -38.17 Million | -4.5 Million | 2.64 Million | -14.91 Million | -22.85 Million |
| Investment purchases | -123.07 Million | -316.31 Million | -67.1 Million | -287.77 Million | -265.36 Million | -174.19 Million |
| Sales/Maturities of investments | 193.44 Million | 118 Million | 64.78 Million | 491.13 Million | 337.58 Million | 360.49 Million |
| Other Investing Activities | - | - | 16.36 Million | -2.64 Million | - | -12.37 Million |
| Financing Cash Flow | -194.01 Million | -610.55 Million | -252.51 Million | -207.77 Million | -385.28 Million | -133.62 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -77.58 Million | -100.06 Million | -89.17 Million | -88.58 Million | -77.49 Million | -66.15 Million |
| Common Stock Repurchased | -152.89 Million | -566.9 Million | -278.06 Million | -196.8 Million | -363.37 Million | -172.61 Million |
| Common Stock Issuance | 37.23 Million | 57.84 Million | 122.08 Million | 82.65 Million | 57.34 Million | 106.16 Million |
| Other Financing Activities | -766 Thousand | -1.43 Million | -7.36 Million | -5.04 Million | -1.75 Million | -1.02 Million |
| Accounts receivables | 43.54 Million | -14.31 Million | -49.03 Million | 1.25 Million | -27.49 Million | -65.72 Million |
| Accounts payables | -83.73 Million | -33.54 Million | 44.23 Million | -45.18 Million | 169 Thousand | 15.69 Million |
| Inventory | -2.42 Million | -11.75 Million | 17.15 Million | -11.78 Million | -16.09 Million | -6.6 Million |
| Other working capital | 42.61 Million | 3.36 Million | -36.98 Million | -25.33 Million | -51 Million | 31.01 Million |
| Cash at beginning of period | 628.37 Million | 1.23 Billion | 1.07 Billion | 805.59 Million | 925.25 Million | 627.01 Million |
| Cash at end of period | 799.15 Million | 628.37 Million | 1.23 Billion | 1.07 Billion | 805.59 Million | 918.06 Million |
| Capital Expenditure | -22.15 Million | -59.45 Million | -54.45 Million | -68.98 Million | -113.53 Million | -85.35 Million |
| Effect of forex changes on cash | 8.81 Million | -16.74 Million | 2.72 Million | 3.93 Million | -5.82 Million | -5.77 Million |
| Net cash flow / Change in cash | 170.78 Million | -604.66 Million | 153.05 Million | 274.38 Million | -119.65 Million | 291.04 Million |
| Free Cash Flow | 259.91 Million | 259.12 Million | 393.29 Million | 274.86 Million | 214.13 Million | 266.84 Million |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.9 Million | 16.4 Million | 191.73 Million | 95.88 Million | 79.44 Million | 183.89 Million |
| Depreciation & Amortization | 24.25 Million | 24.3 Million | 71.25 Million | 24.59 Million | 22.36 Million | 103.6 Million |
| Deferred income taxes | 3.31 Million | -2.1 Million | -21.65 Million | -11.28 Million | -8.25 Million | -29.46 Million |
| Stock-based compensation | 28.19 Million | 29.22 Million | 90.29 Million | 29.82 Million | 31.24 Million | 114.92 Million |
| Change in working capital | 5.28 Million | 49.13 Million | -42.61 Million | -32.43 Million | -63.98 Million | -56.25 Million |
| Other non-cash items | 14.05 Million | 4.17 Million | -6.94 Million | -2.03 Million | -4.41 Million | 1.86 Million |
| Investing Cash Flow | -19.71 Million | 22.03 Million | 73.91 Million | 23.58 Million | 28.3 Million | -295.93 Million |
| Investments in PPE | -8.18 Million | -7.41 Million | -22.15 Million | -7.52 Million | -7.21 Million | -59.45 Million |
| Acquisitions | 11.52 Million | 25.7 Million | 25.7 Million | - | - | -38.17 Million |
| Investment purchases | -49.88 Million | -42.51 Million | -123.07 Million | -7.77 Million | -72.79 Million | -316.31 Million |
| Sales/Maturities of investments | 38.35 Million | 46.25 Million | 193.44 Million | 38.88 Million | 108.3 Million | 118 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -42.79 Million | -36.82 Million | -194.01 Million | -67.09 Million | -90.09 Million | -610.55 Million |
| Debt repayment | -16.97 Million | - | - | - | - | - |
| Dividends payments | -25.82 Million | -25.84 Million | -77.58 Million | -25.87 Million | -25.86 Million | -100.06 Million |
| Common Stock Repurchased | -27.52 Million | -26.81 Million | -152.89 Million | -51.66 Million | -74.41 Million | -566.9 Million |
| Common Stock Issuance | 10.55 Million | 15.83 Million | 37.23 Million | 10.44 Million | 10.95 Million | 57.84 Million |
| Other Financing Activities | - | - | -766 Thousand | - | -766 Thousand | -1.43 Million |
| Accounts receivables | 4.23 Million | 81.31 Million | 43.54 Million | 7.38 Million | -45.15 Million | -14.31 Million |
| Accounts payables | 42.24 Million | -26.55 Million | -83.73 Million | - | 5.76 Million | -33.54 Million |
| Inventory | -10.8 Million | 2.3 Million | -2.42 Million | -4.22 Million | -501 Thousand | -11.75 Million |
| Other working capital | 11.85 Million | -7.93 Million | 42.61 Million | -35.59 Million | -24.09 Million | 3.36 Million |
| Cash at beginning of period | 799.15 Million | 693.42 Million | 628.37 Million | 631.47 Million | 628.37 Million | 1.23 Billion |
| Cash at end of period | 817.96 Million | 799.15 Million | 799.15 Million | 693.42 Million | 631.47 Million | 628.37 Million |
| Capital Expenditure | -8.18 Million | -7.41 Million | -22.15 Million | -7.52 Million | -7.21 Million | -59.45 Million |
| Effect of forex changes on cash | -3.69 Million | -596 Thousand | 8.81 Million | 911 Thousand | 8.5 Million | -16.74 Million |
| Net cash flow / Change in cash | 18.8 Million | 105.73 Million | 170.78 Million | 61.94 Million | 3.1 Million | -604.66 Million |
| Free Cash Flow | 76.83 Million | 113.71 Million | 259.91 Million | 97.01 Million | 49.17 Million | 259.12 Million |
5511
BAC-PS
EFC-PE
4102
300370
6840